Silace Liquid

SILACE  - docusate sodium liquid 
Silarx Pharmaceuticals, Inc


Silace Liquid

Drug Facts

Active ingredient (in each 1 mL)                                     Purpose

Docusate sodium 10 mg . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Stool Softener



Ask doctor before use if you have

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.


Adults and children over 12 years
50 to 200 mg (5-20 mL)
Children 6 to under 12 years
40 to 120 mg (4-12 mL)
Children 3 to under 6 years20 to 60 mg(2-6 mL)
Infants and children under 3 years
Ask a doctor

Other information

Inactive ingredients

citric acid, D&C red no. 33, flavor, methylparaben, Poloxamer, propylene glycol, propylparaben, purified water, sodium citrate.



This product is not manufactured or distributed by Purdue Products LP, distributor of Colace® Liquid.

Manufactured by:

Silarx Pharmaceuticals, Inc.
19 West Street
Spring Valley, NY 10977

Container Label

docusate sodium   liquid
Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)54838-116
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Docusate sodium (Docusate) Docusate sodium10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
anhydrous citric acid 
D&C red no. 33 
propylene glycol 
sodium citrate 
Poloxamer 407 
Product Characteristics
Color    Score    
FlavorLEMON (Lemon Vanilla Flavor) Imprint Code
#NDCPackage DescriptionMultilevel Packaging
154838-116-80473 mL In 1 BOTTLE, PLASTICNone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other10/05/1990

Labeler - Silarx Pharmaceuticals, Inc (161630033)
Revised: 06/2010Silarx Pharmaceuticals, Inc